Skip to main navigation Skip to search Skip to main content

Impact of the minimum pricing policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia

    Research output: Contribution to journalArticlepeer-review

    44 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)295-300
    Number of pages6
    JournalPharmacoepidemiology and Drug Safety
    Volume10
    Publication statusPublished - 2001

    Cite this